Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study

D. L. Schneider, E. L. Barrett-Connor and D. J. Morton
Department of Medicine, University of California, San Diego, La Jolla, USA.

OBJECTIVE: To determine the effect of the timing of initiation and the duration of postmenopausal estrogen therapy on bone mineral density (BMD). DESIGN: Cross-sectional study. SETTING: White, middle-class to upper middle-class community-dwelling women. PARTICIPANTS: A total of 740 women aged 60 to 98 years who participated in a study of osteoporosis. MEASUREMENTS: Questionnaire, validated medication use, and height and weight. Bone mineral density at the ultradistal radius and midshaft radius using single-photon absorptiometry (SPA) and at the hip and lumbar spine using dual-energy x-ray absorptiometry (DEXA). RESULTS: Of the 740 women, 69% had used oral estrogen after menopause and 30% were current users. Five groups of estrogen use were identified: never users, past users who started at menopause, past users who started after age 60 years, current users who started after age 60 years, and current users who started at menopause. At all 4 bone sites, current users who started at menopause had the highest BMD levels, which were significantly higher than never users or past users who started at menopause (with 10 years' duration of use). These differences persisted after controlling for all major risk factors for osteoporosis. Among current users, there was no significant difference in BMD levels at any site between those who started estrogen at menopause (with 20 years of use) and those who started after age 60 years (with 9 years of use). CONCLUSIONS: Estrogen initiated in the menopausal period and continued into late life is associated with the highest bone density. Nevertheless, estrogen begun after age 60 years and continued appears to offer nearly equal bone-conserving benefit.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Premature Graying, Balding, and Low Bone Mineral Density in Older Women and Men: The Rancho Bernardo Study
Morton et al.
J Aging Health 2007;19:275-285.
ABSTRACT  

Effects of Alendronate and Hormone Replacement Therapy, Alone and in Combination, on Bone Mass and Markers of Bone Turnover in Elderly Women with Osteoporosis
Evio et al.
J. Clin. Endocrinol. Metab. 2004;89:626-631.
ABSTRACT | FULL TEXT  

Bone mineral density in postmenopausal Caucasian, Filipina, and Hispanic women
Morton et al.
Int J Epidemiol 2003;32:150-156.
ABSTRACT | FULL TEXT  

Effect of Discontinuation of Estrogen, Calcitriol, and the Combination of Both on Bone Density and Bone Markers
Gallagher et al.
J. Clin. Endocrinol. Metab. 2002;87:4914-4923.
ABSTRACT | FULL TEXT  

Effect of Estrogen Replacement Plus Low-Dose Alendronate Treatment on Bone Density in Surgically Postmenopausal Women with Osteoporosis
Palomba et al.
J. Clin. Endocrinol. Metab. 2002;87:1502-1508.
ABSTRACT | FULL TEXT  

Bone Mass Response to Discontinuation of Long-term Hormone Replacement Therapy: Results From the Postmenopausal Estrogen/Progestin Interventions (PEPI) Safety Follow-up Study
Greendale et al.
Arch Intern Med 2002;162:665-672.
ABSTRACT | FULL TEXT  

Timing of Estrogen Replacement Therapy for Optimal Osteoporosis Prevention
Cauley et al.
J. Clin. Endocrinol. Metab. 2001;86:5700-5705.
ABSTRACT | FULL TEXT  

Soy for Breast Cancer Survivors: A Critical Review of the Literature
Messina and Loprinzi
J. Nutr. 2001;131:3095S-3108.
ABSTRACT | FULL TEXT  

Quality Indicators for the Management of Osteoporosis in Vulnerable Elders
Grossman and MacLean
ANN INTERN MED 2001;135:722-730.
FULL TEXT  

Bone Mineral Density Response to Estrogen Replacement in Frail Elderly Women: A Randomized Controlled Trial
Villareal et al.
JAMA 2001;286:815-820.
ABSTRACT | FULL TEXT  

Hormone replacement therapy (HRT)-- risks and benefits
Barrett-Connor and Stuenkel
Int J Epidemiol 2001;30:423-426.
FULL TEXT  

Anabolic Effect of Estrogen Replacement on Bone in Postmenopausal Women with Osteoporosis: Histomorphometric Evidence in a Longitudinal Study
Khastgir et al.
J. Clin. Endocrinol. Metab. 2001;86:289-295.
ABSTRACT | FULL TEXT  

The Effect of Low Dose Micronized 17{beta}-Estradiol on Bone Turnover, Sex Hormone Levels, and Side Effects in Older Women: A Randomized, Double Blind, Placebo-Controlled Study
Prestwood et al.
J. Clin. Endocrinol. Metab. 2000;85:4462-4469.
ABSTRACT | FULL TEXT  

Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women
Tonino et al.
J. Clin. Endocrinol. Metab. 2000;85:3109-3115.
ABSTRACT | FULL TEXT  

Rapid Loss of Hip Fracture Protection After Estrogen Cessation: Evidence From the National Osteoporosis Risk Assessment
Yates et al.
Obstet Gynecol 2000;103:440-446.
ABSTRACT | FULL TEXT  

Legumes and soybeans: overview of their nutritional profiles and health effects
Messina
Am. J. Clin. Nutr. 1999;70:439S-450.
ABSTRACT | FULL TEXT  

Addition of Alendronate to Ongoing Hormone Replacement Therapy in the Treatment of Osteoporosis: A Randomized, Controlled Clinical Trial
Lindsay et al.
J. Clin. Endocrinol. Metab. 1999;84:3076-3081.
ABSTRACT | FULL TEXT  

Hormone replacement therapy: patterns of use studied through British general practice computerized records
Lawrence et al.
Fam Pract 1999;16:335-342.
ABSTRACT | FULL TEXT  

Alternatives to the Use of Estrogen in Postmenopausal Women
Pinkerton and Santen
Endocr. Rev. 1999;20:308-320.
ABSTRACT | FULL TEXT  

Strategies for Individualizing Patient Decisions About Hormone Therapy
Col et al.
J. Clin. Endocrinol. Metab. 1999;84:1799-1802.
FULL TEXT  

Use of Hormone Replacement Therapy by Postmenopausal Women in the United States
Keating et al.
ANN INTERN MED 1999;130:545-553.
ABSTRACT | FULL TEXT  

Primary Prevention of Postmenopausal Osteoporosis
Levinson and Altkorn
JAMA 1998;280:1821-1822.
FULL TEXT  

Fortnightly review: Hormone replacement therapy
Barrett-Connor
BMJ 1998;317:457-461.
FULL TEXT  

Hormone replacement therapy and risk of hip fracture: population based case-control study
Michaëlsson et al.
BMJ 1998;316:1858-1863.
ABSTRACT | FULL TEXT  

Postmenopausal Hormone-Replacement Therapy -- Time for a Reappraisal?
Brinton and Schairer
NEJM 1997;336:1821-1822.
FULL TEXT  

Estrogen Therapy: Is It Ever Too Late?
Journal Watch Dermatology 1997;1997:18-18.
FULL TEXT  

Estrogen and Bone: It's Never Too Late
JWatch Women's Health 1997;1997:3-3.
FULL TEXT  

ESTROGEN THERAPY: IS IT EVER TOO LATE?
JWatch General 1997;1997:3-3.
FULL TEXT